Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT06236269
Title HR+/HER2- Advanced or Metastatic Breast Cancer Patients Treated With Sacituzumab Govitecan (ACROSS-TROP2)
Acronym ACROSS-TROP2
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors SOLTI Breast Cancer Research Group
Indications
Therapies
Age Groups: senior | adult
Covered Countries ESP

Facility Status City State Zip Country Details
ICO Badalona NOT_YET_RECRUITING Badalona Barcelona 08916 Spain Details
ICO Hospitalet NOT_YET_RECRUITING L'Hospitalet De Llobregat Barcelona 08907 Spain Details
Hospital Universitari Vall d'Hebrón NOT_YET_RECRUITING Barcelona 08035 Spain Details
Hospital Clínic de Barcelona RECRUITING Barcelona 08036 Spain Details
HU Clínico San Cecilio NOT_YET_RECRUITING Granada 18016 Spain Details
Fundación Jiménez Díaz NOT_YET_RECRUITING Madrid 28040 Spain Details
Hospital Universitario 12 de Octubre NOT_YET_RECRUITING Madrid 28041 Spain Details
Hospital Sant Joan de Reus RECRUITING Reus 43204 Spain Details
Hospital Universitario Virgen del Rocio NOT_YET_RECRUITING Sevilla 41013 Spain Details
Hospital Clínico de Valencia NOT_YET_RECRUITING Valencia 46010 Spain Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field